Although the company's advancements have influenced contemporary healthcare, its stock presents a more cautious narrative ...

Tandem (TNDM) stock falls and Insulet (PODD) stock gains as investors react to the companies' Q2 2025 results and guidance.

Headquartered in Galway, Ireland, Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies. With ...

Medtronic's separation of its Medtronic Diabetes unit into a publicly traded company named MiniMed will be a new beginning ...

In the latest close session, Medtronic (MDT) was up +2.1% at $91.24. This move outpaced the S&P 500's daily loss of 0.08%. On the other hand, the Dow registered a loss of 0.51%, and the ...

Medtronic also disclosed severance for a former SVP, and pay for its median employee, and a slight decrease in global employment.

Medtronic announced a spin-off of its diabetes business in May, which will be completed in 2026. Read more on MDT stock here.

Medtronic CEO Geoff Martha's pay rises 16% to $23 million as company beats expectations and plans diabetes unit spinoff.

Orchestra BioMed reported that it has secured over $111 million in financing through a series of transactions and ...

All of those factors make Medtronic an excellent pick for income-seeking investors. It should continue rewarding shareholders ...

Orchestra BioMed announced today that it completed strategic transactions and equity offerings worth an expected $111.2 ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ...